Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × nintedanib × Clear all

NCT01004003 2017-10-26

Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Phase 2 Completed

125 enrolled 19 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00987935 2016-03-10

A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients

Phase 2 Completed

134 enrolled 29 charts

Gastrointestinal

Carcinoma, Hepatocellular